Katarzyna H.
- Country
- Poland
- Department
- N/A
Research Overview
Data & Insights
Has run more than one trial at 0 of 37 partner sites.
Specializations
Thoracic Oncology
The investigator focuses on non-small cell lung cancer and related entities such as ALK‑positive, EGFR‑mutated, KRAS‑G12C, and MET‑altered tumors.
- Advanced ALK‑positive non‑small cell lung cancer
- EGFR exon 20 insertion non‑small cell lung cancer
- KRAS G12C mutant non‑small cell lung cancer
- Small cell lung cancer (extensive‑stage)
- MET exon 14 skipping non‑small cell lung cancer
Clinical activities are performed at Med Polonia Sp. z o.o. in Poznań.
Renal and Urologic Malignancies
Research includes renal cell carcinoma subtypes and urothelial carcinoma of the bladder and upper tract.
- Advanced clear cell renal cell carcinoma
- Metastatic non‑clear cell renal cell carcinoma
- Advanced urothelial carcinoma
- Muscle‑invasive bladder cancer
- Metastatic renal cell carcinoma with sarcomatoid features
Investigations are coordinated through a single research site in Poland.
Gynecologic and Breast Oncology
Key interests span breast cancer, ovarian, endometrial and cervical malignancies.
- Estrogen receptor‑positive breast cancer
- HER‑2 negative advanced breast cancer
- High‑grade serous ovarian cancer
- Advanced cervical cancer
- Endometrial carcinoma
Studies address both early‑stage and metastatic disease settings.
Hematologic Malignancies
The portfolio includes lymphoid and myeloid cancers such as diffuse large B‑cell lymphoma and multiple myeloma.
- Advanced diffuse large B‑cell lymphoma
- Chronic lymphocytic leukaemia
- Multiple myeloma
- Non‑Hodgkin lymphoma
- Platinum‑resistant ovarian cancer with hematologic features
Therapeutic strategies explore targeted agents and immunotherapies.
Autoimmune and Neurological Disorders
Investigations cover immune‑mediated diseases including multiple sclerosis, rheumatoid arthritis, and Sjögren’s syndrome.
- Relapsing‑remitting multiple sclerosis
- Primary progressive multiple sclerosis
- Moderate‑to‑severe rheumatoid arthritis
- Active Sjögren’s syndrome
- Myasthenia gravis (AChR/MuSK antibodies)
Clinical trials evaluate novel immunomodulatory and neuroprotective agents.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.